Infinity Pharmaceuticals, Inc. Share Price
Equities
INFI.Q
US45665G3039
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | 0.00% | 0.00% | -99.96% |
25/03 | North American Morning Briefing : Tech in Focus on -2- | DJ |
25/03 | Infinity Pharmaceuticals, Inc. Went Out of Business | CI |
Sales 2021 | 18.58L 15Cr | Sales 2022 | 25.93L 22Cr | Capitalization | 4.96Cr 412.86Cr |
---|---|---|---|---|---|
Net income 2021 | -4.5Cr -374.67Cr | Net income 2022 | -4.4Cr -366.35Cr | EV / Sales 2021 | 91.8 x |
Net cash position 2021 | 2.97Cr 247Cr | Net Debt 2022 | 1.1Cr 92Cr | EV / Sales 2022 | 23.4 x |
P/E ratio 2021 |
-4.25
x | P/E ratio 2022 |
-1.11
x | Employees | 30 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 97.27% |
1 month | -99.00% | ||
6 months | -99.97% | ||
Current year | -99.96% |
Managers | Title | Age | Since |
---|---|---|---|
Seth Tasker
CEO | Chief Executive Officer | 45 | 01/08/01 |
Jennifer Roberts
PRN | Corporate Officer/Principal | - | 01/17/01 |
Melissa Hackel
PRN | Corporate Officer/Principal | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Anthony Evnin
BRD | Director/Board Member | 83 | 01/06/01 |
Norman Selby
BRD | Director/Board Member | 71 | 12/12/12 |
David W. Beier
BRD | Director/Board Member | 75 | 01/18/01 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
16/24/16 | 0.000001 | 0.00% | 1,936 |
15/24/15 | 0.000001 | 0.00% | 1,094 |
14/24/14 | 0.000001 | 0.00% | 700 |
13/24/13 | 0.000001 | 0.00% | 802 |
09/24/09 | 0.000001 | 0.00% | 1,002 |
End-of-day quote OTC Markets, May 16, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-99.96% | 90 | |
+33.63% | 5.08TCr | |
-0.09% | 4.28TCr | |
+49.62% | 4.2TCr | |
-4.96% | 2.95TCr | |
+11.18% | 2.61TCr | |
-21.95% | 1.91TCr | |
+8.61% | 1.31TCr | |
+28.31% | 1.22TCr | |
+24.73% | 1.21TCr |
- Stock Market
- Equities
- INFI.Q Stock